Octreotide acetate is an artificially synthesized analogue of somatostatin. It is an octapeptide compound composed of amino acids connected by peptide bonds. Its molecular formula is C53H74N10O13S2 • C2H4O2, CAS 83150-76-9, with a relative molecular weight of 1129.38. The chemical properties are relatively stable, but under extreme conditions such as high temperature, strong acid or strong base, decomposition or polymerization reactions may occur. In addition, due to the presence of easily oxidized functional groups such as peptide bonds and thioether bonds, it is also necessary to avoid exposure to air and light conditions. The thermal stability, decomposition temperature, and thermal decomposition kinetics of Octreotide acetate can be studied through thermal analysis techniques such as differential scanning calorimetry and thermogravimetric analysis. These properties are of great significance for evaluating their stability and safety during storage and use. As an artificially synthesized somatostatin analogue, it has a unique chemical structure and various physical properties, which provide an important foundation for its application in the medical field.
(Product link: https://www.bloomtechz.com/synthetic-chemical/api-researching-only/octreotide-acetate-powder-cas-83150-76-9.html)
Octreotide acetate, also known as octreotide acetate in Chinese, is an artificially synthesized analogue of somatostatin. Its molecular structure is as follows:
1. The molecular formula is C54H74N10O13, and the molecular weight is 1029.24. The structure contains an octapeptide main chain and two cysteine residues, which are cross-linked through intermolecular disulfide bonds to form a cyclic structure. In addition, there are acetyl groups attached to the N-terminus of the main chain.
2. The molecular structure is unique and has multiple physiological and pharmacological effects. It has high stability both in vivo and in vitro, and can specifically bind to the somatostatin receptor (SSTR), thereby exerting inhibitory effects on hormone secretion, cell proliferation, and tumor growth. In addition, Octreotide acetate can also inhibit the secretion of glucagon, thereby lowering blood sugar levels.
In order to determine the molecular structure of Octreotide acetate, methods such as spectroscopy, chromatography, and mass spectrometry are commonly used for determination. Among them, nuclear magnetic resonance (NMR) is one of the important means to study its molecular structure. By analyzing the NMR spectrum, information such as the position, chemical environment, and interrelationships of each atom in the Octreotide acetate molecule can be obtained. In addition, techniques such as infrared spectroscopy (IR), Raman spectroscopy (Raman), and X-ray single crystal diffraction can also be used to study its molecular structure.
3. In addition to its molecular structure, the biological activity of Octreotide acetate is also closely related to its conformation. Under physiological conditions, the conformation of Octreotide acetate undergoes a transition from a peptide chain to a disulfide cyclic compound, which enables it to bind to somatostatin receptors and exert biological activity. Therefore, studying the impact of conformational changes in Octreotide acetate on its biological activity is another important research direction.
Octreotide acetate, also known as octreotide acetate in Chinese, is an artificially synthesized octapeptide derivative of natural somatostatin. Its molecular formula is C49H66N10O10S2, with a molecular weight of 1019.239.
1. Stability: Octreotide acetate exhibits high stability both in vivo and in vitro, which is related to the special chemical bonds and conformation in its molecular structure. It has good tolerance, is not easily degraded by enzymes, and can maintain relatively stable pharmacological activity.
2. Specific binding: Octreotide acetate can specifically bind to the somatostatin receptor (SSTR), which makes it important in somatostatin analogues. Somatostatin receptors are mainly distributed in organs such as the pancreas, gastrointestinal tract, and anterior pituitary gland, therefore, Octreotide acetate mainly acts on these organs.
3. Pharmacological effects: Octreotide acetate has various pharmacological effects, including inhibiting growth hormone (GH), increasing pathological secretion of gastrointestinal pancreatic (GEP) endocrine system peptides, and alleviating symptoms and signs related to gastrointestinal pancreatic endocrine tumors. It can also inhibit the release of glucagon and insulin, thereby regulating blood sugar levels. In addition, Octreotide acetate also has anti-tumor effects, which can inhibit the proliferation and spread of tumor cells.
4. Chemical reactivity: Octreotide acetate molecules contain multiple chemical bonds that exhibit different reactivity in different chemical reactions. For example, cysteine residues in molecules can participate in the formation of disulfide bonds between molecules, while acetyl groups can interact with receptor binding sites. The reactivity of these chemical bonds determines the biological activity and pharmacological effects of Octreotide acetate.
5. Metabolism and excretion: The metabolism and excretion pathways of Osteotide acetate in the body mainly include renal excretion and metabolic transformation. It can be excreted from the body in its prototype form through the kidneys, and can also be metabolized and transformed into other metabolites in the liver. Understanding its metabolic and excretory pathways helps to develop rational medication plans and predict drug efficacy.
Octreotide acetate, as an artificially synthesized somatostatin analogue, has unique chemical properties and pharmacological effects. By conducting in-depth research on its chemical structure and properties, more valuable information can be provided for its clinical application, which helps in drug design and optimization, and further expands its application scope in treatment.
The pharmacological effects of Octreotide acetate mainly include inhibiting the secretion of growth hormone, glucagon, and insulin, inhibiting the growth and symptom relief of gastrointestinal and pancreatic endocrine tumors, as well as anti-tumor effects.
1. Firstly, Octreotide acetate can inhibit the secretion of growth hormone, glucagon, and insulin. Too much or too little secretion of these hormones in the human body will lead to a series of diseases, such as diabetes, gastrointestinal and pancreatic endocrine tumors. Octreotide acetate inhibits the secretion of these hormones by specifically binding to somatostatin receptors, thereby playing a therapeutic role in related diseases.
2. Secondly, Octreotide acetate can inhibit the growth and symptom relief of gastrointestinal and pancreatic endocrine tumors. The growth and secretion of hormones by these tumors can cause a series of symptoms, such as gastrointestinal bleeding, abdominal pain, diarrhea, etc. Octreotide acetate can effectively alleviate these symptoms and improve the quality of life of patients by inhibiting the proliferation of tumor cells and hormone secretion.
3. In addition, Octreotide acetate also has anti-tumor effects. It can inhibit the proliferation and spread of tumor cells, reduce the volume of tumors, and prolong the survival period of patients. Especially in the treatment of pancreatic cancer, liver cancer and other malignant tumors, Octreotide acetate has been proved to have a certain effect.
The pharmacological effects of Octreotide acetate are extensive, involving inhibition of growth hormone, glucagon, and insulin secretion, growth and symptom relief of gastrointestinal and pancreatic endocrine tumors, as well as anti-tumor effects. The realization of these pharmacological effects is closely related to their molecular structure and chemical properties. Through in-depth research on their pharmacological mechanisms and chemical properties, more valuable information can be provided for drug design and optimization, which can help develop more effective treatment methods and drugs.